Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review

Ítems similars

• Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review
  per: J. Bryant, et al.
  Publicat: (2001-01-01)
• Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease
  per: Dan-Dan Li, et al.
  Publicat: (2019-05-01)
• QT interval prolongation and with donepezil, rivastigmine and galantamine
  per: Katie Malone, et al.
  Publicat: (2020-08-01)
• The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model
  per: M Bond, et al.
  Publicat: (2012-04-01)
• Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina
  per: Cristiane Bezerra da Silva, et al.
  Publicat: (2016-01-01)